A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Insulin detemir
Etofenamate
The risk or severity of gastrointestinal bleeding can be increased when Etofenamate is combined with Levomilnacipran.
Insulin detemir
Fenbufen
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Levomilnacipran.
Insulin detemir
Floctafenine
The risk or severity of gastrointestinal bleeding can be increased when Floctafenine is combined with Levomilnacipran.
Insulin detemir
Ibuproxam
The risk or severity of gastrointestinal bleeding can be increased when Ibuproxam is combined with Levomilnacipran.
Insulin detemir
Indoprofen
The risk or severity of gastrointestinal bleeding can be increased when Indoprofen is combined with Levomilnacipran.
Insulin detemir
Isoxicam
The risk or severity of gastrointestinal bleeding can be increased when Isoxicam is combined with Levomilnacipran.
Insulin detemir
Kebuzone
The risk or severity of gastrointestinal bleeding can be increased when Kebuzone is combined with Levomilnacipran.
Insulin detemir
Salicylamide
The risk or severity of gastrointestinal bleeding can be increased when Salicylamide is combined with Levomilnacipran.
Insulin detemir
Parecoxib
The risk or severity of gastrointestinal bleeding can be increased when Parecoxib is combined with Levomilnacipran.
Insulin detemir
Azapropazone
The risk or severity of gastrointestinal bleeding can be increased when Azapropazone is combined with Levomilnacipran.
Insulin detemir
Zaltoprofen
The risk or severity of gastrointestinal bleeding can be increased when Zaltoprofen is combined with Levomilnacipran.
Insulin detemir
Cimicoxib
The risk or severity of gastrointestinal bleeding can be increased when Cimicoxib is combined with Levomilnacipran.
Insulin detemir
Benoxaprofen
The risk or severity of gastrointestinal bleeding can be increased when Benoxaprofen is combined with Levomilnacipran.
Insulin detemir
Etoricoxib
The risk or severity of gastrointestinal bleeding can be increased when Etoricoxib is combined with Levomilnacipran.
Insulin detemir
Zomepirac
The risk or severity of gastrointestinal bleeding can be increased when Zomepirac is combined with Levomilnacipran.
Insulin detemir
Indobufen
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Indobufen.
Insulin detemir
Nitroaspirin
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Nitroaspirin.
Insulin detemir
Nimesulide
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Nimesulide.
Insulin detemir
Droxicam
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Droxicam.
Insulin detemir
Dexketoprofen
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Dexketoprofen.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3